• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Oncology

Isolated thrombocytopenia uncommon in children treated for ALL [Pediatrics Classics Series]

byLeah Carr, MDandLewis First, MD
August 14, 2014
in Oncology, Pediatrics, Pediatrics Classics, The Classics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. Among 2239 pediatric patients diagnosed with acute lymphoblastic leukemia, no child met criteria for isolated thrombocytopenia as evidenced by complete blood count, peripheral blood smear, and hepatosplenomegaly on physical exam.

Original Date of Publication: December 1989

Study Rundown: Prior to this study’s publication, children with isolated decreases in platelet counts commonly underwent bone marrow aspiration/biopsy in order to assess for potential leukemia before initiating steroid therapy. As bone marrow examination is an invasive procedure, not without its own risks, this study investigated whether or not this was a necessary practice. Through retrospective analysis of forms prior to the start of a leukemia protocol study, researchers found that none of the 2239 pediatric patients included met criteria for “isolated significant thrombocytopenia” at the time of their leukemia diagnosis. This study is limited by its retrospective nature. Based on this research, investigators concluded that with confirmation of these findings by additional prospective studies, children presenting with likely idiopathic thrombocytopenic purpura (ITP) do not require referral for bone marrow examination. Now, as a result of such studies, children with clear ITP do not undergo bone marrow aspiration and instead are placed on steroid therapy or intravenous immunoglobulin without workup beyond complete blood count (CBC) and physical exam.

Click to read the study in Pediatrics

In-Depth [retrospective cohort study]: Institutions participating in 2 Pediatric Oncology Group acute lymphoblastic leukemia protocols for patients provided prestudy forms from 2239 children with information including the CBC and differential and the presence of hepatosplenomegaly for each patient. The number of patients diagnosed with acute lymphoblastic leukemia and with “isolated significant thrombocytopenia” prior to treatment initiation was then recorded. Isolated thromobocytopenia was defined as a platelet count < 50,000/mm3 without blast cells seen on peripheral blood smear, hemoglobin > 11 g/dL, an absolute neutrophil count (ANC) > 1500/mm3, and no hepatosplenomegaly on physical examination. No children in the study diagnosed with ALL met criteria for “isolated significant thrombocytopenia.”

RELATED REPORTS

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

FDA grants priority review for iberdomide-based myeloma regimen

 © 2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: ALLhematologyITP
Previous Post

Preoperative MRI staging shows no risk reduction of breast cancer recurrence

Next Post

Preperitoneal mesh placement a valid option for ventral hernia repair

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

April 9, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
Variation noted across pre- and post-marketing studies for FDA approved devices
Hematology

FDA grants priority review for iberdomide-based myeloma regimen

March 6, 2026
Reduced venous recanalization after acute deep vein thrombosis associated with post-thrombotic syndrome
Chronic Disease

Effect of high elevation on deep vein thrombosis: a multicenter cohort study

January 22, 2026
Next Post

Preperitoneal mesh placement a valid option for ventral hernia repair

Antepartum and intrapartum events both linked to neonatal HIE

Levetiracetam exposure in utero not associated with neurodevelopmental delays

Proper passenger restraint use linked to parental race

Proper passenger restraint use linked to parental race

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Maternal use of benzodiazepines and non-benzodiazepine hypnotics is not associated with increased risk of psychiatric
  • Sparsentan (Filspari) becomes first approved treatment for focal segmental glomerulosclerosis
  • A non-invasive neurostimulation intervention may improve social communication impairment in children with autism spectrum disorder
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.